Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$152.58
+0.1%
$153.75
$140.68
$169.99
$366.71B0.428.02 million shs9.00 million shs
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$290.10
+1.0%
$261.55
$190.90
$292.35
$797.91B1.089.53 million shs12.69 million shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.00%+1.76%-1.65%-8.11%+4.30%
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
0.00%+4.57%+8.84%+16.95%+42.05%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.9556 of 5 stars
3.35.04.23.93.01.71.9
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
4.7919 of 5 stars
2.24.04.22.02.73.32.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.55
Moderate Buy$170.8812.00% Upside
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
2.39
Hold$273.15-5.84% Downside

Current Analyst Ratings Breakdown

Latest JNJ and JPM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/27/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Strong Sell
6/27/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeNeutral ➝ Underperform$235.00
6/25/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$250.00 ➝ $275.00
6/23/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$236.00 ➝ $240.00
6/18/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$300.00 ➝ $325.00
6/10/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$300.00 ➝ $320.00
6/5/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$181.00
6/4/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
6/2/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
6/2/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
6/2/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight
(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$88.82B4.13$13.13 per share11.62$29.69 per share5.14
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$278.91B2.89$22.25 per share13.04$115.33 per share2.52
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$8.9916.9713.782.3124.42%33.46%13.30%7/16/2025 (Estimated)
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$58.47B$20.3714.2414.942.6721.21%16.88%1.31%7/15/2025 (Estimated)

Latest JNJ and JPM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/16/2025Q2 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.65N/AN/AN/A$22.85 billionN/A
7/15/2025Q2 2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$4.45N/AN/AN/A$43.76 billionN/A
4/15/2025Q1 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.59$2.77+$0.18$4.54$21.65 billion$21.89 billion
4/11/2025Q1 2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$4.63$5.07+$0.44$5.07$43.62 billion$45.30 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.203.41%N/A57.84%64 Years
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$5.601.93%N/A27.49%15 Years

Latest JNJ and JPM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/19/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
quarterly$1.402.12%7/3/20257/3/20257/31/2025
4/15/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.303.37%5/27/20255/27/20256/10/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.49
1.26
1.03
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
1.23
0.89
0.89

Institutional Ownership

CompanyInstitutional Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
71.55%

Insider Ownership

CompanyInsider Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
0.47%
CompanyEmployeesShares OutstandingFree FloatOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,1002.41 billion2.40 billionOptionable
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
317,2332.78 billion2.77 billionOptionable

Recent News About These Companies

Markets Close Rollercoaster Q2 on Top
Bond rally cools just as another index inclusion nears

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$152.58 +0.17 (+0.11%)
As of 03:58 PM Eastern

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

JPMorgan Chase & Co. stock logo

JPMorgan Chase & Co. NYSE:JPM

$290.10 +2.99 (+1.04%)
As of 03:58 PM Eastern

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.